Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Teruo Murakami, Erik Bodor & Nicholas Bodor. (2023) Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: part 2. development of oral dosage formulations. Expert Opinion on Drug Metabolism & Toxicology 19:3, pages 139-148.
Read now
Read now
Yuan Kong, Lin Li, Lin-Guo Zhao, Pan Yu & Dong-Dong Li. (2022) A patent review of berberine and its derivatives with various pharmacological activities (2016–2020). Expert Opinion on Therapeutic Patents 32:2, pages 211-223.
Read now
Read now
Sam Maher, Caroline Geoghegan & David J. Brayden. (2021) Intestinal permeation enhancers to improve oral bioavailability of macromolecules: reasons for low efficacy in humans. Expert Opinion on Drug Delivery 18:2, pages 273-300.
Read now
Read now
Mitali H. Patel, Veenu P. Mundada & Krutika K. Sawant. (2019) Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, in vitro characterization, cell line studies and in vivo efficacy in schizophrenia. Drug Development and Industrial Pharmacy 45:8, pages 1242-1257.
Read now
Read now
Fiona McCartney, John P. Gleeson & David J. Brayden. (2016) Safety concerns over the use of intestinal permeation enhancers: A mini-review. Tissue Barriers 4:2.
Read now
Read now
Seung Rim Hwang, In Jae Kim & Jin Woo Park. (2015) Formulations of deoxycholic for therapy: a patent review (2011 – 2014). Expert Opinion on Therapeutic Patents 25:12, pages 1423-1440.
Read now
Read now
Christian Tscheik, Ingolf E. Blasig & Lars Winkler. (2013) Trends in drug delivery through tissue barriers containing tight junctions. Tissue Barriers 1:2.
Read now
Read now
Articles from other publishers (24)
Nobuhiro Mori, Keisuke Oda, Hideki Takakura, Yusuke Tanaka, Tomoharu Yokooji & Teruo Murakami. (2023) Comparison of Berberine Bioavailability between Oral and Rectal Administrations in Rats. Biological and Pharmaceutical Bulletin 46:11, pages 1639-1642.
Crossref
Crossref
Célia Marques, Maria Helena Fernandes & Sofia A. Costa Lima. (2023) Elucidating Berberine’s Therapeutic and Photosensitizer Potential through Nanomedicine Tools. Pharmaceutics 15:9, pages 2282.
Crossref
Crossref
Yang Gao, Jianmei Sun, Shucong Wang, Lisong Huxiao, Yali Xu & Hailong Zhang. (2023) DSPE-PEG polymer enhanced berberine absorption specifically in the small intestine of rats through paracellular passway. Journal of Pharmacy and Pharmacology 75:7, pages 931-939.
Crossref
Crossref
Fengjiao Xu, Meiyan Liu, Yating Liao, Ya Zhou, Peng Zhang, Youlin Zeng & Zhonghua Liu. (2022) Improvement of anticancer effect of berberine by salt formation modifications. Phytomedicine 104, pages 154314.
Crossref
Crossref
Maisarah Azman, Akmal H. Sabri, Qonita Kurnia Anjani, Mohd Faiz Mustaffa & Khuriah Abdul Hamid. (2022) Intestinal Absorption Study: Challenges and Absorption Enhancement Strategies in Improving Oral Drug Delivery. Pharmaceuticals 15:8, pages 975.
Crossref
Crossref
Md Ali Mujtaba, Md Habban Akhter, Md. Sarfaraz Alam, Mohammad Daud Ali & Afzal Hussain. (2022) An Updated Review on Therapeutic Potential and Recent Advances in Drug Delivery of Berberine: Current Status and Future Prospect. Current Pharmaceutical Biotechnology 23:1, pages 60-71.
Crossref
Crossref
Shikha Lohan, Teenu Sharma, Sumant Saini, Arti Singh, Anil Kumar, Kaisar Raza, Jalseen Kaur & Bhupinder Singh. (2021) Galactosylated nanoconstructs of Berberine with enhanced Biopharmaceutical and cognitive potential: A preclinical evidence in Alzheimer ‘s disease. Journal of Drug Delivery Science and Technology 66, pages 102695.
Crossref
Crossref
Sarika Narade & Yogesh Pore. (2021) ASSESSMENT OF PERMEABILITY BEHAVIOR OF BERBERINE CHLORIDE ACROSS GOAT INTESTINAL MEMBRANE IN PRESENCE OF NATURAL BIOPOTENTIATOR CURCUMIN. INDIAN DRUGS 58:4, pages 23-27.
Crossref
Crossref
Feifei Qiu, Weihui Lu, Shulin Ye, Huazhen Liu, Qiaohuang Zeng, Haiding Huang, Chun-Ling Liang, Yuchao Chen, Fang Zheng, Qunfang Zhang, Chuan-Jian Lu & Zhenhua Dai. (2021) Berberine Promotes Induction of Immunological Tolerance to an Allograft via Downregulating Memory CD8+ T-Cells Through Altering the Gut Microbiota. Frontiers in Immunology 12.
Crossref
Crossref
Meng Li, Wenjun Zhou, Yanqi Dang, Chunlin Li, Guang Ji & Li Zhang. (2020) Berberine compounds improves hyperglycemia via microbiome mediated colonic TGR5-GLP pathway in db/db mice. Biomedicine & Pharmacotherapy 132, pages 110953.
Crossref
Crossref
Xiaolei Ma, Tingting Zhang, Zhigang Luo, Xiaolin Li, Miao Lin, Rui Li, Peng Du, Xiaoyou Yu, Chen Ma, Pengju Yan, Jin Su, Lulu Wang, Yuhuan Li & Jiandong Jiang. (2020) Functional nano-vector boost anti-atherosclerosis efficacy of berberine in Apoe() mice. Acta Pharmaceutica Sinica B 10:9, pages 1769-1783.
Crossref
Crossref
Belén Begines, Tamara Ortiz, María Pérez-Aranda, Guillermo Martínez, Manuel Merinero, Federico Argüelles-Arias & Ana Alcudia. (2020) Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects. Nanomaterials 10:7, pages 1403.
Crossref
Crossref
Sok Kuan Wong, Kok-Yong Chin & Soelaiman Ima-Nirwana. (2020) Berberine and musculoskeletal disorders: The therapeutic potential and underlying molecular mechanisms. Phytomedicine 73, pages 152892.
Crossref
Crossref
Hui-Hui Guo, Chen-Lin Feng, Wen-Xuan Zhang, Zhi-Gang Luo, Hong-Juan Zhang, Ting-Ting Zhang, Chen Ma, Yun Zhan, Rui Li, Song Wu, Zeper Abliz, Cong Li, Xiao-Lin Li, Xiao-Lei Ma, Lu-Lu Wang, Wen-Sheng Zheng, Yan-Xing Han & Jian-Dong Jiang. (2019) Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases. Nature Communications 10:1.
Crossref
Crossref
Jingfu Jia, Kerong Zhang, Xue Zhou, Dan Zhou & Fahuan Ge. (2018) Precise Dissolution Control and Bioavailability Evaluation for Insoluble Drug Berberine via a Polymeric Particle Prepared Using Supercritical CO2. Polymers 10:11, pages 1198.
Crossref
Crossref
Yanwen Wang & Jeffrey A. Zidichouski. (2018) Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis. Cholesterol 2018, pages 1-17.
Crossref
Crossref
Y. Gao, X. Jin, Y. Sun, F.F. Xu & M. Zhang. (2018) Production and investigation of sustained berberine pellet drug release system. Advanced Powder Technology 29:3, pages 682-691.
Crossref
Crossref
Antonello Santini & Ettore Novellino. (2017) Nutraceuticals in hypercholesterolaemia: an overview. British Journal of Pharmacology 174:11, pages 1450-1463.
Crossref
Crossref
Mohamed Amine Djebbi, Alae Elabed, Zaineb Bouaziz, Moulay Sadiki, Soumya Elabed, Philippe Namour, Nicole Jaffrezic-Renault & Abdesslem Ben Haj Amara. (2016) Delivery system for berberine chloride based on the nanocarrier ZnAl-layered double hydroxide: Physicochemical characterization, release behavior and evaluation of anti-bacterial potential. International Journal of Pharmaceutics 515:1-2, pages 422-430.
Crossref
Crossref
Guofei Li, Fan Yang, Mei Liu, Xianying Su, Mingming Zhao & Limei Zhao. (2016) Development and application of a UPLC-MS/MS method for simultaneous determination of fenofibric acid and berberine in rat plasma: application to the drug-drug pharmacokinetic interaction study of fenofibrate combined with berberine after oral administrati. Biomedical Chromatography 30:7, pages 1075-1082.
Crossref
Crossref
Chang-Shun Liu, Yu-Rong Zheng, Ying-Feng Zhang & Xiao-Ying Long. (2016) Research progress on berberine with a special focus on its oral bioavailability. Fitoterapia 109, pages 274-282.
Crossref
Crossref
David J. Brayden, Sam Maher, Bojlul Bahar & Edwin Walsh. (2015) Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol. European Journal of Pharmaceutics and Biopharmaceutics 94, pages 194-206.
Crossref
Crossref
David J. Brayden & Edwin Walsh. (2014) Efficacious Intestinal Permeation Enhancement Induced by the Sodium Salt of 10-undecylenic Acid, A Medium Chain Fatty Acid Derivative. The AAPS Journal 16:5, pages 1064-1076.
Crossref
Crossref
Chandraiah Godugu, Apurva R. Patel, Ravi Doddapaneni, Jaganmohan Somagoni & Mandip Singh. (2014) Approaches to Improve the Oral Bioavailability and Effects of Novel Anticancer Drugs Berberine and Betulinic Acid. PLoS ONE 9:3, pages e89919.
Crossref
Crossref